Opioid Overdose Reversal Kits Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

The global opioid overdose reversal kits market is expected to grow at a CAGR of around 10.8% during 2024-2033. This report on global opioid overdose reversal kits market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global opioid overdose reversal kits market by segmenting the market based on route of administration, extraction process, end user, distribution channel and region. Also, detailed profiles of companies operating in the opioid overdose reversal kits market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

 

 

Market Drivers

The opioid overdose reversal kits market is propelled by multiple factors. The growing awareness of the overdose of opioid coupled with aggressive treatment across globe is contributing in market growth. Additionally, there has been an increase in dependency on drugs. For instance, data released by the World Health Organization in August 2021 indicated that around 0.5 million deaths globally are related to drug usage, with overdose accounting for over 30% of these deaths and opioids accounting for over 70% of these deaths. Moreover, according to the data provided by the Centers for Disease Control and Prevention, 2021, the national public health agency of the U.S. in November 2021, over 100,306 drug overdose deaths were reported in U.S. during 12-month period ending in April 2021. Many naloxone manufacturers, commercial companies, and governmental agencies are concentrating on programs to lower the number of deaths associated with opioid overdoses by expanding public access to medications like naloxone.

 

Market Restraints

The market’s growth is anticipated to be significantly hampered by low naloxone awareness and accessibility. For example, naloxone was recognized as an essential drug by the World Health Organization (WHO), but just a third of EU (European Union) member states had access to it in 2016, according to statistics provided by the European Monitoring Centre for Drugs and Drug Addiction. Therefore, it is anticipated that a major barrier to the market’s expansion will be the limited availability of naloxone in these crucial areas.

 

Market Opportunities

Among the factors expected to support market expansion in the upcoming years is the incorporation of technology, such as smart devices or mobile apps, to improve the usability and functionality of opioid overdose kits. One aspect that is expected to support market expansion in the upcoming years is the incorporation of technology, such as smart devices or mobile apps, to improve the usability and functionality of opioid overdose kits. For example, businesses are concentrating on creating and promoting naloxone autoinjectors that are simple to use and are intended to make administering the antidote in emergency scenarios easier.

 

Recent Industry Development 

• In Jan 2024, EG America started offering Opioid Overdose Reversal Kits at Cumberland Farms, Fastrac.
• In May 2023, FDA approved Opvee, a nasal spray which is similar to naloxone.
• In Dec 2023, Emergent BioSolutions seek the approval from FDA to sell Narcan (overdose-reversal nasal spray) over the counter.

 

Historical & Forecast Period

Base Year: 2023

Historical Period: 2019-2023

Forecast Period: 2024-2033

Report’s Unit: US$

 

Global Opioid Overdose Reversal Kits Market Segmentation

Market by Route of Administration

• Injectables
• Nasal
• Oral

Market by Extraction Process

• Solvent Extracted
• Cold-Pressed

Market by End User

• Hospitals
• Ambulatory Surgical Centers
• Rehabilitation

Market by Distribution Channel

• Hospital
• Retail
• Online
• Other Channels

Market by Region

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe

North America

• United States
• Canada

Asia Pacific

• China
• Japan
• India
• South Korea
• Australia
• ASEAN
• Rest of Asia Pacific

Latin America

• Mexico
• Brazil
• Argentina
• Chile
• Rest of Latin America

Middle East & Africa

• Saudi Arabia
• Turkey
• Iran
• United Arab Emirates
• Rest of Middle East & Africa

 

List of Mentioned Companies

• Amphastar Pharmaceuticals, Inc.
• BD (Becton Dickinson and Company)
• Emergent BioSolutions Inc. (acquired Adapt Pharma Inc.)
• Indivior PLC (acquired Opiant Pharmaceuticals Inc.)
• Kaleo Inc.
• Kern Pharma
• Mundipharma International Limited
• Novartis AG
• Pfizer Inc. (Hospira Inc.)
• UCB Pharma Limited.

 

Report Coverage

Report Feature	Details
Base Year	2023
Historical Period	2019-2022
Forecast Period	2024-2033
Units	US$ Million
Segments Covered	Route of Administration, Extraction Process, End User, Distribution Channel, Region
Region Covered	Europe, North America, Asia Pacific, Latin America, Middle East and Africa
Companies Covered	Amphastar Pharmaceuticals, Inc., BD (Becton Dickinson and Company), Emergent BioSolutions Inc. (acquired Adapt Pharma Inc.), Indivior PLC (acquired Opiant Pharmaceuticals Inc.), Kaleo Inc., Kern Pharma, Mundipharma International Limited, Novartis AG, Pfizer Inc. (Hospira Inc.), UCB Pharma Limited.
Purchase Options	Single User License: US$ 2,999 Five User License: US$ 3,499 Corporate License: US$ 4,499

 

Research Methodology

During the course of the research study, we conducted extensive primary and secondary research. The research commenced with extensive exploration through secondary sources followed by primary research. With these research methods, we were able to estimate the market size, to identify the factors that promote the growth in this market as well as the factors that hamper the growth in the market.

Comprehensive primary and secondary methods helped us to identify the trends in the market and to project the opportunities that the key players may get during the forecast period. Apart from these approaches, various analytical and statistical approaches were also used during data extraction cleaning, and analysis. 

Post-secondary & primary research, we conducted expert interviews to validate all the information we collected during the course of the study. So, a blend of these three-way approaches helped us in data triangulation and to provide an accurate market scenario in our report.

 

Key Questions Answered in the Report

• What will be the global opioid overdose reversal kits food market size and the growth rate in the coming year?
• What are the main key factors driving the market?
• What are the key market trends impacting the growth of the market?
• What are the market opportunities and threats in the market?
• What industrial trends, drivers, and challenges are manipulating its growth?
• Which are trending factors influencing the market shares of the top regions across the globe?
• Who are the key market players in the industry?
• What is the impact of Covid19 on the current industry?

1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
2.1. Global Market in 2023
2.2. Impact of COVID-19
2.3. Growth Opportunities and Challenges
2.4. Key Industry Trends
3. Global Opioid Overdose Reversal Kits Market Dynamics
3.1. Introduction
3.2. Market DROs
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Industry Trends
3.4. SWOT Analysis
3.5. Market Value Chain Analysis
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Key Price Indicators
3.9. Ansoff Matrix
3.10. Government Laws and Industry Regulations
4. Global Opioid Overdose Reversal Kits Market Analysis
4.1. Market Portraiture
4.2. Market Size (US$ Million, 2019-2023)
4.3. Market Forecast (US$ Million, 2024-2033)
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Opioid Overdose Reversal Kits Market by Route of Administration (US$ Million, 2019-2033)
5.1. Introduction
5.2. Injectables
5.3. Nasal
5.4. Oral
5.5. Key Segment Investment Opportunity
6. Global Opioid Overdose Reversal Kits Market by Extraction Process (US$ Million, 2019-2033)
6.1. Introduction
6.2. Solvent Extracted
6.3. Cold-Pressed
6.4. Key Segment Investment Opportunity
7. Global Opioid Overdose Reversal Kits Market by End User (US$ Million, 2019-2033)
7.1. Introduction
7.2. Hospitals
7.3. Ambulatory Surgical Centers
7.4. Rehabilitation
7.5. Key Segment Investment Opportunity
8. Global Opioid Overdose Reversal Kits Market by Distribution Channel (US$ Million, 2019-2033)
8.1. Introduction
8.2. Hospital
8.3. Retail
8.4. Online
8.5. Other Channels
8.6. Key Segment Investment Opportunity
9. Global Opioid Overdose Reversal Kits Market by Region (US$ Million, 2019-2033)
9.1. Introduction
9.2. Europe
9.3. North America
9.4. Asia Pacific
9.5. Latin America
9.6. Middle East & Africa
9.7. Key Segment Investment Opportunity
10. Europe Opioid Overdose Reversal Kits Market (US$ Million, 2019-2033)
10.1. Introduction
10.2. Key Drivers and Takeaways
10.3. Europe Market Breakup by Route of Administration
10.4. Europe Market Breakup by Extraction Process
10.5. Europe Market Breakup by Technology
10.6. Europe Market Breakup by Material
10.7. Europe Market Breakup by End User
10.8. Europe Market Breakup by Distribution Channel
10.9. Europe Market Breakup by Country
10.9.1. Germany
10.9.2. United Kingdom
10.9.3. France
10.9.4. Italy
10.9.5. Spain
10.9.6. Russia
10.9.7. Netherlands
10.9.8. Sweden
10.9.9. Poland
10.9.10. Rest of Europe
11. North America Opioid Overdose Reversal Kits Market (US$ Million, 2019-2033)
11.1. Introduction
11.2. Key Drivers and Takeaways
11.3. North America Market Breakup by Route of Administration
11.4. North America Market Breakup by Extraction Process
11.5. North America Market Breakup by End User
11.6. North America Market Breakup by Distribution Channel
11.7. North America Market Breakup by Country
11.7.1. United States
11.7.2. Canada
12. Asia Pacific Opioid Overdose Reversal Kits Market (US$ Million, 2019-2033)
12.1. Introduction
12.2. Key Drivers and Takeaways
12.3. Asia Pacific Market Breakup by Route of Administration
12.4. Asia Pacific Market Breakup by Extraction Process
12.5. Asia Pacific Market Breakup by End User
12.6. Asia Pacific Market Breakup by Distribution Channel
12.7. Asia Pacific Market Breakup by Country
12.7.1. China
12.7.2. Japan
12.7.3. India
12.7.4. South Korea
12.7.5. Australia
12.7.6. ASEAN
12.7.7. Rest of Asia Pacific
13. Latin America Opioid Overdose Reversal Kits Market (US$ Million, 2019-2033)
13.1. Introduction
13.2. Key Drivers and Takeaways
13.3. Latin America Market Breakup by Route of Administration
13.4. Latin America Market Breakup by Extraction Process
13.5. Latin America Market Breakup by End User
13.6. Latin America Market Breakup by Distribution Channel
13.7. Latin America Market Breakup by Country
13.7.1. Mexico
13.7.2. Brazil
13.7.3. Argentina
13.7.4. Chile
13.7.5. Rest of Latin America
14. Middle East and Africa Opioid Overdose Reversal Kits Market (US$ Million, 2019-2033)
14.1. Introduction
14.2. Key Drivers and Takeaways
14.3. Middle East and Africa Market Breakup by Route of Administration
14.4. Middle East and Africa Market Breakup by Extraction Process
14.5. Middle East and Africa Market Breakup by End User
14.6. Middle East and Africa Market Breakup by Distribution Channel
14.7. Middle East and Africa Market Breakup by Country
14.7.1. Saudi Arabia
14.7.2. Turkey
14.7.3. Iran
14.7.4. United Arab Emirates
14.7.5. Rest of Middle East & Africa
15. Competitive Landscape
15.1. Competitive Dashboard
15.2. Key Industry Strategies Analysis
15.3. Recent Developments
15.4. Market Scenario
16. Company Profiles
16.1. Amphastar Pharmaceuticals, Inc.
16.2. BD (Becton Dickinson and Company)
16.3. Emergent BioSolutions Inc. (acquired Adapt Pharma Inc.)
16.4. Indivior PLC (acquired Opiant Pharmaceuticals Inc.)
16.5. Kaleo Inc.
16.6. Kern Pharma
16.7. Mundipharma International Limitedv
16.8. Novartis AG
16.9. Pfizer Inc. (Hospira Inc.)
16.10. UCB Pharma Limited.